Get started
Author

Stuart J Nixon

Observed name: Stuart Nixon
Observed institution: Multiple Sclerosis Society
OpenAlex ID: A5073788346
Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey
2021 · Rubina Shah, Faraz M Ali, et al. · BMJ Open · 127
PDF
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK
2024 · James Blackstone, Thomas Williams, et al. · BMJ Open · 21
PDF
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial
2025 · Jeremy Chataway, Thomas Williams, et al. · The Lancet · 17
Meaning of Family Reported Outcome Measure (FROM-16) severity score bands: a cross-sectional online study in the UK
2023 · Rubina Shah, Andrew Y Finlay, et al. · BMJ Open · 17
PDF
Multiple sclerosis greatly impacts family members/partners: Evidence using the Family Reported Outcome Measure (FROM-16)
2025 · Rubina Shah, Sam Salek, et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 4
Beyond the burden: Measuring the quality of life impact of Parkinson's on family members/partners using FROM-16
2026 · Rubina Shah, Sam Salek, et al. · Journal of Parkinson s Disease
Cost of care for people with secondary progressive multiple sclerosis: baseline results from the MS-STAT2 study
2025 · Ekaterina Bordea, Jennifer Nicholas, et al. · Research Square
Works count: 7
Citation count: 186
H-index: 4
I10-index: 4
Year
Topic
Type